• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Brand Quest
• The New Manager
• BL Club
• Smartbuy

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth
• Events 2007

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Hyderabad, Nov. 4 Pharma major Dr Reddy’s Laboratories Ltd will focus on “green chemistry” to make the process of drug design and manufacture more environmental friendly.

“We have been trying to be sustainable in our drug production for the last five years. However, we will focus more on this front and initiate internal measuring of green chemistry,” Mr G.V. Prasad, Vice-Chairman and Chief Executive Officer of Dr Reddy’s, told newspersons here on Tuesday while briefing about its Sustainability Report 2008.

The step is aimed at integrating eco-friendly measures into the process of drug production.

“This can be defined as making a given molecule with maximum atomic efficiency, i.e., using least number of atoms,” Mr Prasad explained.

The company is also taking other measures such as sending some of the by-products to other sectors in which they can be used effectively. “Sodium sulphate, for instance, is being sent to the construction industry where it can be used in producing other materials,” he said.

The company is also in the process of making its building “green”, he added.

The Hyderabad-based company has been bringing out the sustainability report since 2004 to mention its efforts in creating additional value to shareholders, environmental protection practice and corporate social responsibility.

More Stories on : Outlook | Pharmaceuticals | Dr. Reddy's Laboratories Ltd

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Copyright © 2008, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line